Rich ML, Khan UT, Zeng C, LaHood AN, Franke MF, et al.
2023-06-01 • International Journal of Tuberculosis and Lung Disease
2023-06-01 • International Journal of Tuberculosis and Lung Disease
BACKGROUND Evidence of the effectiveness of the WHO-recommended design of longer individualized regimens for multidrug- or rifampicin-resistant TB (MDR/RR-TB) is limited.
Siddiquea BN, Islam MS, Bam TS, Satyanarayana S, Enarson D, et al.
2013-09-21 • Public Health Action
2013-09-21 • Public Health Action
SETTING BRAC, a non-governmental organisation, implemented a modified smoking cessation programme for tuberculosis (TB) patients based on International Union Against Tuberculosis and...
Hossain ST, Isaakidis P, Sagili KD, Islam S, Islam MS, et al.
2015-06-25 • PLOS One
2015-06-25 • PLOS One
OBJECTIVES To determine, in areas supported by BRAC, Bangladesh i) the pre-diagnosis and pre-treatment attrition among presumptive and confirmed Multi-Drug Resistant Tuberculosis (MD...
Eisenberg N, Panunzi I, Wolz A, Burzio C, Cilliers A, et al.
2021-10-05 • Clinical Infectious Diseases
2021-10-05 • Clinical Infectious Diseases
BACKGROUND Diphtheria has re-emerged over the past several years. There is a paucity of data on the administration and safety of diphtheria antitoxin (DAT), the standard treatment fo...